| Business Summary | | CellMetrix,
Inc.
is
a
medical
technology
company
that
will
supply
a
cost-effective
system
of
cell
and
tissue
analysis
to
provide
physicians
and
other
health
care
professionals
a
method
for
the
early
detection
of
cancer.
The
Company
is
engaged
in
the
development
and
sale
of
clinical
testing
applications
and
automated
laboratory
systems
that
together
allow
for
the
early
detection,
diagnosis,
characterization,
treatment
and
monitoring
of
significant
human
diseases.
The
Company
currently
is
focused
on
developing
clinical
testing
applications
for
lung
cancer
and
has
already
fully
developed
and
begun
marketing
its
first
clinical
application
called
LungCheck
to
targeted
healthcare
providers
who
treat
people
that
are
`at-risk'
for
lung
disease. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | CLMI
is
a
medical
technology
company
whose
products
identify
the
presence
of
the
most
common
forms
of
lung
irritants
and
monitor
cellular
abnormalities
in
the
lungs.
For
the
six
months
ended
6/30/00,
net
revenues
rose
54%
to
$20
thousand.
Net
loss
increased
66%
to
$1.8
million.
Revenues
reflect
increased
product
sales.
Higher
losses
suffered
from
increased
S/G/A
expenses
due
to
consulting
and
compensation
charges
related
to
the
issuance
of
stock
options. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY1999 Pay | |
| Michael Strauss, 58 Chairman,
Pres, CEO | $131K | Karen Tantone Corp.
Sec. and Mang. of Admin. | -- | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|